Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
Standard
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS). / Mossner, M; Jann, J-C; Nowak, D; Platzbecker, U; Giagounidis, A; Götze, K; Letsch, A; Haase, D; Shirneshan, K; Braulke, F; Schlenk, R F; Haferlach, T; Schafhausen, P; Bug, G; Lübbert, M; Ganser, A; Büsche, G; Schuler, E; Nowak, V; Pressler, J; Obländer, J; Fey, S; Müller, N; Lauinger-Lörsch, E; Metzgeroth, G; Weiß, C; Hofmann, W-K; Germing, U; Nolte, F.
in: LEUKEMIA, Jahrgang 30, Nr. 9, 09.2016, S. 1956-9.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
AU - Mossner, M
AU - Jann, J-C
AU - Nowak, D
AU - Platzbecker, U
AU - Giagounidis, A
AU - Götze, K
AU - Letsch, A
AU - Haase, D
AU - Shirneshan, K
AU - Braulke, F
AU - Schlenk, R F
AU - Haferlach, T
AU - Schafhausen, P
AU - Bug, G
AU - Lübbert, M
AU - Ganser, A
AU - Büsche, G
AU - Schuler, E
AU - Nowak, V
AU - Pressler, J
AU - Obländer, J
AU - Fey, S
AU - Müller, N
AU - Lauinger-Lörsch, E
AU - Metzgeroth, G
AU - Weiß, C
AU - Hofmann, W-K
AU - Germing, U
AU - Nolte, F
PY - 2016/9
Y1 - 2016/9
KW - Journal Article
U2 - 10.1038/leu.2016.111
DO - 10.1038/leu.2016.111
M3 - Other (editorial matter etc.)
C2 - 27133825
VL - 30
SP - 1956
EP - 1959
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 9
ER -